9.42
-0.62 (-6.13%)
| 前收盘价格 | 10.04 |
| 收盘价格 | 9.96 |
| 成交量 | 4,798,456 |
| 平均成交量 (3个月) | 3,010,646 |
| 市值 | 2,050,480,000 |
| 价格/销量 (P/S) | 2.32 |
| 股市价格/股市净资产 (P/B) | 0.970 |
| 52周波幅 | |
| 利润日期 | 9 Apr 2026 |
| 营业毛利率 | -53.56% |
| 营业利益率 (TTM) | 2.45% |
| 稀释每股收益 (EPS TTM) | -2.23 |
| 季度收入增长率 (YOY) | -3.40% |
| 总债务/股东权益 (D/E MRQ) | 33.61% |
| 流动比率 (MRQ) | 3.91 |
| 营业现金流 (OCF TTM) | 68.45 M |
| 杠杆自由现金流 (LFCF TTM) | 1.26 M |
| 资产报酬率 (ROA TTM) | 0.59% |
| 股东权益报酬率 (ROE TTM) | -16.71% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Neogen Corporation | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.88 |
|
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 0.38% |
| 机构持股比例 | 128.88% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Clarkston Capital Partners, Llc | 31 Dec 2025 | 11,328,670 |
| Ing Groep Nv | 31 Dec 2025 | 8,777,500 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合